Kathryn de Santis

Investor Relations Contact chez

Sucampo Pharma Americas, Inc.

Health Technology

Consumer Services

Profil

Kathryn de Santis is currently the VP-Investor Relations & Corporate Communications at Sucampo Pharma Americas, Inc. She previously held the same position at Sucampo Pharmaceuticals, Inc. and was the Director-Corporate Communications at Human Genome Sciences, Inc. She received an undergraduate degree from Molloy College and an MBA from Pace University.

Postes actifs de Kathryn de Santis

Sociétés	Poste	Début
Sucampo Pharma Americas, Inc.	Investor Relations Contact	-

Tous les postes actifs de Kathryn de Santis

Anciens postes connus de Kathryn de Santis

Sociétés	Poste	Fin
SUCAMPO PHARMACEUTICALS, INC.	Investor Relations Contact	29/06/2012
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products	Public Communications Contact	-

Voir l'expérience en détail de Kathryn de Santis

Formation de Kathryn de Santis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kathryn de Santis

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products	Health Technology
Molloy College Molloy College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pace University Pace University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sucampo Pharmaceuticals LLC Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products	Health Technology
Sucampo Pharma Americas, Inc.